- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Acute Myeloid Leukemia
Medical specialists from France tagged as investigators in clinical trials studying Acute Myeloid Leukemia
Total 264 results
-
B. LioureSeen in:
- Strasbourg, FR-Strasbourg cedex-HAUTEPIERRE
Trials:- NCT04027309 (Principal Investigator)
-
Béatrice FERVERSSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Benoit DE RENZIS, MDSeen in:
- Clermont-Ferrand, CHU Estaing
Trials:- NCT03223961 (Principal Investigator)
- NCT03454984 (Principal Investigator)
Conditions: -
Benoite MERYSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Bérangère GRUSONSeen in:
- Amiens, C.H.U d'Amiens - Hôpital Sud
Trials:- NCT02473146 (Principal Investigator)
Conditions: -
Berthon Céline, MDSeen in:
- Lille, CHRU Lille
Trials:- NCT03594149 (Principal Investigator)
Conditions: -
Bertrand SARDINSeen in:
- Limoges, CHU Limoges
Trials:- NCT03800095 (Sub-Investigator)
-
Bruno QuesnelSeen in:
- Lille, FR-Lille-CHULILLE
- Lille, Hôpital Claude HURIEZ, CHU Lille
- Lille, Hôpital Huriez, CHU de Lille
Trials:- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT02473146 (Principal Investigator)
-
C.E. BulaboisSeen in:
- Grenoble cedex 9, FR-Grenoble cedex 9-CHUGRENOBLE
Trials:- NCT04027309 (Principal Investigator)
-
Caroline Lejeune, MDSeen in:
- Saint-Etienne, CHU de Saint-Etienne
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT03439371 (Sub-Investigator)
- NCT04517656 (Sub-Investigator)
- NCT05259553 (Sub-Investigator)
- NCT03233074 (Sub-Investigator)
-
Cecile BallySeen in:
- Paris, Hôpital Necker
Trials:- NCT02649790 (Principal Investigator)
-
Cécile Braticevic, MDSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT03595787 (Principal Investigator)
Conditions: -
Cécile LAUDESeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Cécile PautasSeen in:
- Creteil, Hopital Henri Mondor
- Créteil, CHU Henri Mondor
Trials:- NCT05260528 (Principal Investigator)
- NCT02473146 (Principal Investigator)
Conditions: -
Celine BerthonSeen in:
- Lille, CHU de Lille
- Lille, Hôpital Claude HURIEZ, CHU Lille
Trials:- NCT04067336 (Principal Investigator)
- NCT05260528 (Principal Investigator)
-
Chantal HimberlinSeen in:
- Reims, FR-Reims-CHREIMS
Trials:- NCT04027309 (Principal Investigator)
-
Cheze Stephane, MdSeen in:
- Caen, CHU Caen
Trials:- NCT03594149 (Principal Investigator)
Conditions: -
Christelle DE LA FOUCHARDIERESeen in:
- Lyon, CAC - Léon Bernard
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
- NCT02885753 (Sub-Investigator)
-
Christelle FAURESeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Christelle Portois, PhDSeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT03233074 (Sub-Investigator)
-
Christian CARRIESeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Christian Recher, Dr.Seen in:
- Toulouse, CHU de Toulouse
Trials:- NCT04086264 (Principal Investigator)
Conditions: -
Christian ROSE, profSeen in:
- Lille, Hôpital Saint-Vincent de Paul
- Lille, Hôpital St Vincent de Paul
Trials:- NCT03223961 (Principal Investigator)
- NCT03454984 (Principal Investigator)
Conditions: -
Christiane Mounier, PhDSeen in:
- Saint-Étienne, CHU de Saint-Etienne
Trials:- NCT03233074 (Sub-Investigator)
-
Claire BORIES, DrSeen in:
- Lens, LENS CHR
Trials:- NCT05070208 (Sub-Investigator)
Conditions: -
Claude GARDIN, MDSeen in:
- Bobigny, CH Avicenne
Trials:- NCT02473146 (Principal Investigator)
Conditions: -
Claude-Eric BulaboisSeen in:
- Grenoble, Centre Hospitalier Universitaire de Grenoble
Trials:- NCT03439371 (Principal Investigator)
Conditions:
Clinical Trials on Acute Myeloid Leukemia
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingSecondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Xuzhou Medical UniversityRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryChina